Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gustavo Drügg Hahn
Observed names:
G Drügg Hahn,
G Hahn,
Gustavo Hahn
Institutions:
Universidade Federal do Rio Grande do Sul,
Hospital de Clínicas de Porto Alegre,
McGill University
Observed institutions:
Universidade Federal do Rio Grande do Sul,
Universidade Federal de Ciências da Saúde de Porto Alegre,
Santa Casa Hospital,
McGill University Health Centre,
Hospital Moinhos de Vento,
Hospital de Clínicas de Porto Alegre,
McGill University
show all 7
ORCID:
0000-0003-1963-7848
Observed ORCID:
0000-0003-1963-7848
OpenAlex ID:
A5070796301
The Optimal Management of Fistulizing Crohn’s Disease: Evidence beyond Randomized Clinical Trials
2022
·
Panu Wetwittayakhlang
, Alex Al Khoury
, et al.
·
Journal of Clinical Medicine
·
42
PDF
Treatment Targets in Ulcerative Colitis: Is It Time for All In, including Histology?
2021
·
Panu Wetwittayakhlang
, Livia Lontai
, et al.
·
Journal of Clinical Medicine
·
36
PDF
A prospective randomized trial of intralesional triamcinolone injections after endoscopic dilation for complex esophagogastric anastomotic strictures
2014
·
Júlio C. Pereira-Lima
, Michele Lemos Bonotto
, et al.
·
Surgical Endoscopy
·
36
Clinical Outcomes of COVID‐19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease
2021
·
Panu Wetwittayakhlang
, Farah Albader
, et al.
·
Canadian Journal of Gastroenterology and Hepatology
·
30
PDF
Safety of Biological Therapies in Elderly Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis
2022
·
Gustavo Drügg Hahn
, Petra Anna Golovics
, et al.
·
Journal of Clinical Medicine
·
25
PDF
Is There a Best First Line Biological/Small Molecule in IBD: Are We Ready for Sequencing?
2022
·
Gustavo Drügg Hahn
, Petra Anna Golovics
, et al.
·
Biomedicines
·
13
PDF
Effectiveness, safety, and drug sustainability of biologics in elderly patients with inflammatory bowel disease: A retrospective study
2022
·
Gustavo Drügg Hahn
, Jean-Frédéric LeBlanc
, et al.
·
World Journal of Gastroenterology
·
11
Increased Prevalence of Myocardial Infarction and Stable Stroke Proportions in Patients with Inflammatory Bowel Diseases in Quebec in 1996–2015
2022
·
Petra Anna Golovics
, Christine Verdon
, et al.
·
Journal of Clinical Medicine
·
10
PDF
Mucosal Healing and Clinical Efficacy of Adalimumab in Small Intestinal Crohn’s Disease (SIMCHA Study): Final Results From a Prospective, Open-Label, Single-Arm Study
2023
·
Panu Wetwittayakhlang
, Christine Verdon
, et al.
·
The Turkish Journal of Gastroenterology
·
7
PDF
Adherence to Objective Therapeutic Monitoring and Outcomes in Patients with Inflammatory Bowel Disease with Adalimumab Treatment. A Real-world Prospective Study
2022
·
Panu Wetwittayakhlang
, Petra A Golovics
, et al.
·
Journal of Gastrointestinal and Liver Diseases
·
6
PDF
Hereditary Nonpolyposis Colorectal Cancer in Association with Crohn’s Disease and Lynch Syndrome: The Importance of a Strict Endoscopic Surveillance
2022
·
Gustavo Drügg Hahn
, Panu Wetwittayakhlang
, et al.
·
Case Reports in Gastroenterology
·
4
Defining Fecal Calprotectin Cutoffs That Predict Endoscopic and Histologic Remission in Patients With Ulcerative Colitis
2025
·
Gustavo Drügg Hahn
, Peter Laszlo Lakatos
, et al.
·
Inflammatory Bowel Diseases
·
2
P318 Safety of Biological Therapies in Elderly IBD: a Systematic Review and Meta-analysis
2022
·
G Drügg Hahn
, P Golovics
, et al.
·
Journal of Crohn s and Colitis
·
2
P412 Faecal Calprotectin as a predictor of endoscopic and histologic remission in patients with Ulcerative Colitis
2024
·
G Drügg Hahn
, C Flores
, et al.
·
Journal of Crohn s and Colitis
PDF
Tu1441: EVALUATING DRUG SUSTAINABILITY, EFFICACY AND SAFETY OF BIOLOGIC AGENTS IN ELDERLY PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER RETROSPECTIVE STUDY
2022
·
Petra A. Golovics
, Jean-Frederic Leblanc
, et al.
·
Gastroenterology
Mo1566: MUCOSAL HEALING AND CLINICAL REMISSION AFTER TREATMENT WITH ADALIMUMAB IN SMALL INTESTINAL CROHN’S DISEASE (SIMCHA STUDY): FINAL RESULTS FROM A PROSPECTIVE, OPEN-LABEL, SINGLEARM STUDY
2022
·
Panu Wetwittayakhlang
, Petra A. Golovics
, et al.
·
Gastroenterology
Su1571: SAFETY OF BIOLOGICAL THERAPIES IN ELDERLY IBD: A SYSTEMATIC REVIEW AND META-ANALYSIS
2022
·
Gustavo Hahn
, Petra A. Golovics
, et al.
·
Gastroenterology
A143 Safety of Biological Therapies in Elderly Ibd: a Systematic Review
2022
·
P Golovics
, G Drügg Hahn
, et al.
·
Journal of the Canadian Association of Gastroenterology
PDF
A180 Clinical Outcomes of Covid-19 and Impact on Disease Course in Patients With Inflammatory Bowel Disease
2022
·
P Wetwittayakhlang
, F Albader
, et al.
·
Journal of the Canadian Association of Gastroenterology
PDF
P451 Evaluating drug sustainability, efficacy and safety of biologic agents in elderly patients with Inflammatory Bowel Disease: a single center retrospective study
2022
·
P Golovics
, J F LeBlanc
, et al.
·
Journal of Crohn s and Colitis
DOP25 Clinical outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease
2022
·
P Wetwittayakhlang
, F Albader
, et al.
·
Journal of Crohn s and Colitis
P321 Mucosal Healing and Clinical remission after Treatment with Adalimumab in Small Intestinal Crohn’s Disease (SIMCHA study): final results from a prospective, open-label, single-arm study
2022
·
P Wetwittayakhlang
, P Golovics
, et al.
·
Journal of Crohn s and Colitis
PDF
Prevalence of Micturition Disorders and its Effectiveness in Outpatient Treatment
2014
·
Alexandre Fornari
, Marina Gressler
, et al.
·
ics.org
Show more works
View as search
Works count:
23
Citation count:
224
H-index:
8
I10-index:
8
Year
Topic
Type